Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-9560
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring ; volume:11 ; number:1 ; day:28 ; month:6 ; year:2013 ; pages:1-17 ; date:12.2013
Thrombosis journal ; 11, Heft 1 (28.6.2013), 1-17, 12.2013
- Urheber
-
Mueck, Wolfgang
Schwers, Stephan
Stampfuss, Jan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1477-9560-11-10
- URN
-
urn:nbn:de:101:1-2019101320065260512760
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mueck, Wolfgang
- Schwers, Stephan
- Stampfuss, Jan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effects of direct oral anticoagulants dabigatran and rivaroxaban on the blood coagulation function in rabbits
Rivaroxaban Pharmacokinetics in Obese Subjects: A Systematic Review
Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis
Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism
Standard coagulation assays alone are not sufficient to exclude surgically relevant rivaroxaban plasma concentrations
Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants
Evaluation of the Efficacy and Safety of Rivaroxaban Using a Computer Model for Blood Coagulation
Mechanistic Basis for the Differential Effects of Rivaroxaban and Apixaban on Global Tests of Coagulation
Forschungswerkstatt Rivaroxaban 2014
Active Online Assessment of Patients Using New Oral Anticoagulants: Bleeding Risk, Compliance, and Coagulation Analysis
Patient compliance with new oral anticoagulants after major orthopaedic surgery: rivaroxaban and dabigatran compared with subcutaneous injection of fondaparinux
Pharmacokinetics of Direct Oral Anticoagulants in Emergency Situations: Results of the Prospective Observational RADOA-Registry
Effects of direct oral anticoagulants dabigatran and rivaroxaban on the blood coagulation function in rabbits
Rivaroxaban Pharmacokinetics in Obese Subjects: A Systematic Review
Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis
Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism
Standard coagulation assays alone are not sufficient to exclude surgically relevant rivaroxaban plasma concentrations
Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants
Evaluation of the Efficacy and Safety of Rivaroxaban Using a Computer Model for Blood Coagulation
Mechanistic Basis for the Differential Effects of Rivaroxaban and Apixaban on Global Tests of Coagulation
Forschungswerkstatt Rivaroxaban 2014
Active Online Assessment of Patients Using New Oral Anticoagulants: Bleeding Risk, Compliance, and Coagulation Analysis
Patient compliance with new oral anticoagulants after major orthopaedic surgery: rivaroxaban and dabigatran compared with subcutaneous injection of fondaparinux
Pharmacokinetics of Direct Oral Anticoagulants in Emergency Situations: Results of the Prospective Observational RADOA-Registry
Effects of direct oral anticoagulants dabigatran and rivaroxaban on the blood coagulation function in rabbits
Rivaroxaban Pharmacokinetics in Obese Subjects: A Systematic Review
Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis
Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism
Standard coagulation assays alone are not sufficient to exclude surgically relevant rivaroxaban plasma concentrations
Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants
Evaluation of the Efficacy and Safety of Rivaroxaban Using a Computer Model for Blood Coagulation
Mechanistic Basis for the Differential Effects of Rivaroxaban and Apixaban on Global Tests of Coagulation
Forschungswerkstatt Rivaroxaban 2014
Active Online Assessment of Patients Using New Oral Anticoagulants: Bleeding Risk, Compliance, and Coagulation Analysis
Patient compliance with new oral anticoagulants after major orthopaedic surgery: rivaroxaban and dabigatran compared with subcutaneous injection of fondaparinux